2m 2m 2m 2m 2m 2m 2m
RELMADA THERAPEU (RLMD)
NASDAQ
$4.64+$0.010 (+0.22%)
Price as of Aug 21, 2026 7:30 PM EDT- $493.9MMarket Cap
- 638.44%1-Year Change
- BiotechnologyIndustry
RELMADA THERAPEU (RLMD)
$4.64+$0.010 (+0.22%)
RLMD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.63 | ||
Change | -$0.010 (-0.22%) | ||
Open | $4.68 | ||
High | $4.76 | ||
Low | $4.54 | ||
Previous Close | $4.64 | ||
Volume | 985,172 | ||
30-Day Average Volume | 1,270,834 | ||
1-Week Change | -3.54% | ||
1-Month Change | -12.64% | ||
1-Year Change | 638.44% | ||
3-Year Change | 54.33% | ||
5-Year Change | -79.36% | ||
Fundamentals | |||
Shares Outstanding | 106.7M | ||
Total Assets | $219.1M | ||
Market Cap | $493.9M | ||
Enterprise Value | $482.5M | ||
Period: QTR TTM FY | |||
Revenue | -$204,552.00 | ||
Net Income | -$12.9M | ||
Free Cash Flow | -$9.6M | ||
EBIT | -$12.9M | ||
EBITDA | -$12.9M | ||
Net Working Capital | $211.6M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -37 | ||
Enterprise Value/Revenue | -2,359 | ||
P/B | 2 | ||
P/E | -42 | ||
PEG | -1 | ||
Price/Free Cash Flow | -51 | ||
Price/Operating Cash Flow | -51 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 09/30/2019 | ||
Earnings & Revenue